Accéder au contenu
Merck

Multidrug-resistant tuberculosis that required 2 years for diagnosis.

BMJ case reports (2012-05-19)
Shuichi Yano, Kanako Kobayashi, Toshikazu Ikeda
RÉSUMÉ

Isoniazid (H) or rifampicin (R) mono-resistant disease can be treated easily and effectively with first-line drugs, while combined H and R resistance (ie, multidrug-resistant tuberculosis (MDRTB)) requires treatment with at least four agents, including a quinolone and an injectable agent. Drug-resistant Mycobacterium tuberculosis strains are reported to be extremely difficult to cultivate invitro. The authors report a case of MDRTB that required 2 years for diagnosis, and was detected only in sputum culture on solid medium. Physicians should consider MDRTB if TB is suspected but pathogens are not detected.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
4-Aminosalicylic acid, 99%
Sigma-Aldrich
Sodium 4-aminosalicylate dihydrate, ≥97.0% (T)